Vogirite M 500mg/0.3mg Tablet SR
Marketer
Foregen Healthcare Ltd
Salt Composition
Metformin (500mg) + Voglibose (0.3mg)
Overview Vogirite M 500mg/0.3mg Tablet SR
Diabetease-M 500mg/0.3mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation manages type 2 diabetes in adults by regulating blood glucose. Administer Diabetease-M with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on your blood sugar response. Continuous use is vital, even with controlled glucose levels; abrupt cessation without medical guidance risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Diabetease-M is one component of a comprehensive diabetes management plan, which includes a doctor-recommended diet, exercise regimen, and weight management. Lifestyle choices significantly impact diabetes control. Possible side effects include nausea, altered taste perception, appetite changes, gas, abdominal discomfort, diarrhea, and skin reactions. These are generally transient and self-limiting. Persistent or concerning side effects warrant immediate medical consultation. Your doctor can offer strategies to mitigate or treat bothersome side effects. Do not use Diabetease-M if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver impairment. Inform your doctor of any history of heart disease before starting this medication, as it may be unsuitable. Pregnant or lactating individuals should seek medical advice prior to use. Regular blood glucose monitoring is essential, along with potential blood tests to track blood cell counts and liver function.
Primary Ingredients of Vogirite M 500mg/0.3mg Tablet SR
There is no text provided to rewrite.
Uses of Vogirite M 500mg/0.3mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Vogirite M 500mg/0.3mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Vogirite M 500mg/0.3mg Tablet SR. Ingest the tablet whole; do not break, crush, or chew it. Administer this medication with a meal.
Common Side effects of Vogirite M 500mg/0.3mg Tablet SR:
- Flatulence
- Diarrhea
- Abdominal pain
- Vomiting
- Decreased appetite
How to use Vogirite M 500mg/0.3mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Vogirite M 500mg/0.3mg Tablet SR. Ingest the tablet whole; do not fracture, pulverize, or chew it. Administer this medication with a meal.
How Vogirite M 500mg/0.3mg Tablet SR works:
Vogirite M 500mg/0.3mg extended-release tablets contain a dual antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Vogirite M 500mg/0.3mg SR tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The extended-release Vogirite M 500mg/0.3mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible hazards prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Vogirite M 500mg/0.3mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingSAFE
The extended-release Vogirite M 500mg/0.3mg tablet generally does not impair driving ability. Nevertheless, individuals using this medication concurrently with other antidiabetic drugs, including sulfonylureas, insulin, or repaglinide, should be aware of the potential for low blood sugar.
KidneyCAUTION
Patients with kidney impairment should use Vogirite M 500mg/0.3mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Vogirite M 500mg/0.3mg SR tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCONSULT YOUR DOCTOR
Data regarding the use of Vogirite M 500mg/0.3mg sustained-release tablets in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Vogirite M 500mg/0.3mg Tablet SR :
Should you forget a Vogirite M 500mg/0.3mg Tablet SR dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vogirite M 500mg/0.3mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently